Nicotine in neuropsychiatric movement disorders;Nikotin bei neuropsychiatrischen Bewegungsstorungen

Fortschritte der Neurologie Psychiatrie

Volumn 64, Issue 9, 1996, Pages 362-366

  Erdmann, R ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NICOTINE; DOPAMINE RECEPTOR;

CHOLINERGIC SYSTEM; DOPAMINERGIC SYSTEM; GILLES DE LA TOURETTE SYNDROME; HUMAN; MOTOR DYSFUNCTION; PARKINSON DISEASE; REVIEW; TIC; ADULT; AKATHISIA; BRAIN; CHILD; DRUG EFFECT; DYSKINESIA; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AKATHISIA, DRUG-INDUCED; BRAIN; CHILD; DYSKINESIA, DRUG-INDUCED; HALOPERIDOL; HUMANS; NICOTINE; PARKINSON DISEASE; RECEPTORS, DOPAMINE; TOURETTE SYNDROME;

EID: 0030228085     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996579     Document Type: Review

References (42)

1. Arevalo, E., W. L. Licamele, S. Bronheim, K. Sonnenschein: Nicotine gum in Tourette's disorder (comment). Am. J. Psychiatry 149 (1992) 417-418
2. Baron, J. A.: Cigarette smoking and Parkinson's disease. Neurology 36 (1986) 1490-1496
3. Binder, R. L., H. Kazamaturi, T. Nishimura, D. E. McNiel: Smoking and tardive dyskinesia. Biol. Psychiat. 22 (1987) 1280-1282
4. Decina, P., G. Caracci, R. Sandik, W. Herman, S. Mukherjee, P. Scapicchio: Cigarette smoking and neuroleptic-induced parkinsonism. Biol. Psychiatry 28 (1990) 502-508
5. Deuschl, G., W. Oertel, W. Poewe: Früh- und Differentialdiagnose des Parkinson-Syndroms, Dt. Ärzteblatt 91 (1994) (Sonderdruck) 1115-1124
6. Devor, E. J., K. E. Isenberg: Nicotine and Tourette's Syndrome. Lancet (1989) 1046
7. Dimitsopulos, T., R. Kurlan: Tourette's Syndrome and nicotine withdrawal. J. Neuropsychiatry Clin. Neurosci. 5 (1993) 108-109
8. Dose, M.: Neuroleptisch bedingte Spätdyskinesien: Definition, Symptomatik, Diagnostik, Prävalenz, Hypothesen zur Entstehung, Risikofaktoren, Therapie und Prävention. Synthelabo Arzneimittel GmbH, Schürholz Arzneimittel GmbH (Hrsg.): Puchheim 1993
9. Dursun, S. M., M. A. Reveley, R. Bird, F. Stirton: Longlasting improvement of Tourette's syndrome with transdermal nicotine. Lancet 344 (1994) 1577
10. Erdmann, R., U. Schneider: Nikotin und Tourette-Syndrom. Psychiatrische Prax. 23 (1996), im Druck
11. Fagerström, K. O., O. Pomerleau, B. Giordani, F. Stelson: Nicotine may relieve symptoms of Parkinson's disease. Psychopharmacology 116 (1994) 117-119
12. Fuxe, K., A. M. Janson, A. Jansson, K. Andersson, P. Eneroth, L. F. Agnati: Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection. Naunyn-Schmiedeberg's. Arch. Pharmacol. 341 (1990) 171-181
13. Gibb, W. R. G., A. J. Lees: A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 38 (1988) 1402-1406
14. Golbe, L. I., R. A. Cody, R. C. Duvoisin: Smoking and Parkinson's disease. Search for a dose-response relationship. Arch. Neurol. 43 (1986) 774-778
15. Hemmings, G.: Biochemistry of schizophrenia and addiction. MTP Press. Lancaster 1980
16. Hinterhuber, H., Ch. Haring: Unerwünschte Wirkungen, Kontraindikationen, Überdosierungen, Intoxikationen. In: Riederer, P., G. Laux, W. Pöldinger (Hrsg.): Neuro-Psychopharmaka, Bd. 4. Springer, Wien (1992) 102-121
17. Hughes, J. R., D. K. Hatsukami, J. E. Mitchell, L. A. Dahlgren: Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry 143 (1986) 993-997
18. Ishikawa, A., T. Miyatake: Effects of smoking in patients with early-onset Parkinson's disease. Journal of the Neurological Sciences 117 (1993) 28-32
19. Jaffe, J. H.: Drug addiction and drug abuse. In: Goodman Gilman, A., L. S. Goodman, A. Gilman (eds.): The Pharmacological Basis of Therapeutics. Macmillan, New York, Toronto (1980) 535-584
20. Kirch, D. G., A.-M. Alho, R. J. Wyatt: Hypothesis: A nicotine-dopamine interaction linking smoking with Parkinson's Disease and tardive dyskinesia. Cellular and Molecular Neurobiology 8 (1988) 285-291
21. Kurlan, R.: Tourette's syndrome: current concepts. Neurology 39 (1989) 1625-1630
22. Le Houezec, J.: Central nervous system pharmacology of nicotine. In: Adis international (ed.): Future directions in nicotine replacement therapy. Chester, England (1994) 1-6
23. McConville, B. J., M. H. Fogelson, A. B. Norman, W. M. Klykylo, P. Z. Manderscheid, K. W. Parker, P. R. Sanberg: Nicotine potentiation of haloperidol in reducing tic frequency in tourette's disorder, Am. J. Psychiatry 148 (1991) 793-794
24. McConville, B. J., A. B. Norman: Nicotine gum in Tourette's disorder. Am. J. Psychiatry 149 (1992a) 418
25. McConville, B. J., P. R. Sanberg, M. H. Fogelson, J. King, P. Cirino, K. W. Parker, A. B. Norman: The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine in reducing tic severity and frequency in Tourette's disorder. Biol. Psychiatry 31 (1992b) 832-840
26. Menza, M. A., N. Grossman, M. van Horn, R. Cody, N. Forman: Smoking and movement disorders in psychiatric patients. Biol. Psychiatry 30 (1991) 109-115
27. Moll, H.: The treatment of post encephalitic parkinsonism by nicotine. Br. Med. J. 1 (1926) 1079-1081
28. Morens, D. M., A. Grandinetti, D. Reed, L. R. White, G. W. Ross: Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? Neurology 45 (1995) 1041-1051
29. Norton, R., K. Brown, R. Howard: Smoking, nicotine dose and the lateralisation of electrocortical activity. Psychopharmacology 108 (1992) 473-479
30. 2- dopamine receptor density. Biochem. Biophys. Res. Commun. 159 (1989) 48-52
31. Rickards, E. H. G.: Nicotine gum in Tourette's Disorder (Comment). Am. J. Psychiatry 149 (1992) 417
32. Riggs, J. E.; Cigarette smoking and Parkinson disease: the illusion of a neuroprotective effect. Clin. Pharmacol. 15 (1992) 88-99
33. Rothenberger, A.: The role of the frontal lobes in child psychiatric disorders. In: Rothenberger, A. (ed.): Brain and Behavior in Child Psychiatry. Springer, Berlin, Heidelberg, New York (1990) 34-58
34. Sahakian, B., G. Jones, R. Levy, J. Gray, D. Warburton: The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer Type. Brit. J. Psychiatry 154 (1989) 797-800
35. Sanberg, P. R., H. M. Fogelson, P. Z. Manderscheid, K. W. Parker, A. B. Norman, B. J. McConville: Nicotine gum and haloperidol in Tourette's syndrome. Lancet (1988) 592
36. Sanberg, P. R., B. J. McConville, H. M. Fogelson, P. Z. Manderscheid, K. W. Parker, M. M. Blythe, W. M. Klykylo, A. B. Norman: Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome. Biomed. Pharmacother. 43 (1989) 19-23
37. Schauenburg, H., D. Dressler: Das Gilles-de-la-Tourette-Syndrom. Nervenarzt 63 (1992) 453-461
38. Schöny, W., H. Rittmannsberger: Praktische Durchführung, allgemeine Behandlungsrichtlinien. In: Riederer, P., G. Laux, W. Pöldinger (Hrsg.): Neuro-Psychopharmaka, Bd. 4, Springer, Wien (1992) 131-152
39. Silver, A. A., P. R. Sanberg: Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome. Lancet (1993) 182
40. Wagner, B., G. K. Wolf, G. Ulmar: Does smoking reduce the risk of neuroleptic parkinsonoids? Pharmacopsychiat. 21 (1988) 302-303
41. Yassa, R., S. Lal, A. Korpassy, J. Ally: Nicotine exposure and tardive dyskinesia, Biol. Psychiat. 22 (1987) 67-72
42. Youssef, H. A., J. L. Waddington: Morbidity and mortality in tardive dyskinesia: associations in chronic schizophrenia, Acta Psychiatr. Scand. 75 (1987) 74-77